Literature DB >> 7560610

High prevalence of antibodies against beta 1- and beta 2-adrenoceptors in patients with primary electrical cardiac abnormalities.

P A Chiale1, M B Rosenbaum, M V Elizari, A Hjalmarson, Y Magnusson, G Wallukat, J Hoebeke.   

Abstract

OBJECTIVES: This study sought to determine the prevalence of autoantibodies directed against the beta-adrenoceptors in patients with primary electrical cardiac abnormalities, including atrial arrhythmias, ventricular arrhythmias and conduction disturbances, in the absence of any other cardiac abnormality.
BACKGROUND: Using synthetic peptides corresponding to the predicted sequences for the second extracellular loop of the human beta 1- and beta 2-adrenoceptors as antigenic targets, autoantibodies directed against the beta-adrenoceptors were recently shown to occur in patients with idiopathic dilated cardiomyopathy and Chagas' heart disease.
METHODS: Eighty-six patients (57 with primary electrical abnormalities, 29 with idiopathic dilated cardiomyopathy) and 101 healthy and cardiopathic control subjects were studied. Antibodies against the beta 1- and beta 2-peptides were detected with an enzyme immunoassay performed in blinded manner. In nine selected (seropositive) cases, the immunoglobulin G (IgG) fraction was tested for functional effects on the rate of beating of cultured neonatal rat cardiomyocytes.
RESULTS: Antibodies recognizing the beta 1- and beta 2-peptides were found in 11 (52.3%) of 21 patients with ventricular arrhythmias (p < 0.01), 5 (35.7%) of 14 patients with conduction disturbances (p < 0.05), 3 (13.6%) of 22 patients with atrial arrhythmias (p > 0.05) and 11 (37.9%) of 29 patients with dilated cardiomyopathy (p < 0.05) compared with 15 (14.8%) of 101 control subjects. A rapid increase in the rate of beating of the cultured cardiomyocytes was induced by IgG from a selected group of patients, suggesting an agonist-like interaction with a functional epitope. This response was mediated by stimulation of both the beta 1- and beta 2-adrenoceptors in the patients with primary ventricular arrhythmias but only the beta 1-adrenoceptors in the patients with idiopathic dilated cardiomyopathy.
CONCLUSIONS: Primary ventricular arrhythmias and conduction disturbances, like idiopathic cardiomyopathy, show a high prevalence of antibodies interacting with functional epitopes of the beta-adrenoceptors, suggesting a common or similar abnormal immunoregulatory process.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7560610     DOI: 10.1016/0735-1097(95)00262-2

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  23 in total

Review 1.  Inverse agonism at G protein-coupled receptors: (patho)physiological relevance and implications for drug discovery.

Authors:  R A de Ligt; A P Kourounakis; A P IJzerman
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

Review 2.  Role of autoantibodies in the physiopathology of Chagas' disease.

Authors:  Emiliano Horacio Medei; José Hamilton Matheus Nascimento; Roberto Coury Pedrosa; Antônio Carlos Campos de Carvalho
Journal:  Arq Bras Cardiol       Date:  2008-10       Impact factor: 2.000

3.  Antibodies with beta-adrenergic activity from chronic chagasic patients modulate the QT interval and M cell action potential duration.

Authors:  Emiliano Horacio Medei; José H M Nascimento; Roberto C Pedrosa; Luciane Barcellos; Masako O Masuda; Serge Sicouri; Marcelo V Elizari; Antonio C Campos de Carvalho
Journal:  Europace       Date:  2008-05-30       Impact factor: 5.214

Review 4.  Autoantibodies as Endogenous Modulators of GPCR Signaling.

Authors:  Meredith A Skiba; Andrew C Kruse
Journal:  Trends Pharmacol Sci       Date:  2020-12-24       Impact factor: 14.819

5.  Antibodies to ribosomal P proteins of Trypanosoma cruzi in Chagas disease possess functional autoreactivity with heart tissue and differ from anti-P autoantibodies in lupus.

Authors:  D Kaplan; I Ferrari; P L Bergami; E Mahler; G Levitus; P Chiale; J Hoebeke; M H Van Regenmortel; M J Levin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

Review 6.  Autoimmune pathogenesis of Chagas heart disease: looking back, looking ahead.

Authors:  Kevin M Bonney; David M Engman
Journal:  Am J Pathol       Date:  2015-04-07       Impact factor: 4.307

7.  Elevated M2-muscarinic and β1-adrenergic receptor autoantibody levels are associated with paroxysmal atrial fibrillation.

Authors:  Muhammed U Yalcin; Kadri M Gurses; Duygu Kocyigit; Sacit Altug Kesikli; Ahmet Hakan Ates; Banu Evranos; Hikmet Yorgun; Mehmet L Sahiner; Ergun B Kaya; Mehmet A Oto; Dicle Guc; Necla Ozer; Kudret Aytemir
Journal:  Clin Res Cardiol       Date:  2014-10-29       Impact factor: 5.460

Review 8.  Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases.

Authors:  Gerd Wallukat; Ingolf Schimke
Journal:  Semin Immunopathol       Date:  2014-04-29       Impact factor: 9.623

9.  A peptidomimetic inhibitor suppresses the inducibility of β1-adrenergic autoantibody-mediated cardiac arrhythmias in the rabbit.

Authors:  Hongliang Li; Ling Zhang; Bing Huang; Vineet Veitla; Benjamin J Scherlag; Madeleine W Cunningham; Christopher E Aston; David C Kem; Xichun Yu
Journal:  J Interv Card Electrophysiol       Date:  2015-10-07       Impact factor: 1.900

10.  Atrial tachycardia provoked in the presence of activating autoantibodies to β2-adrenergic receptor in the rabbit.

Authors:  Hongliang Li; Benjamin J Scherlag; David C Kem; Caitlin Zillner; Shailesh Male; Sorkko Thirunavukkarasu; Xiaohua Shen; Jan V Pitha; Madeleine W Cunningham; Ralph Lazzara; Xichun Yu
Journal:  Heart Rhythm       Date:  2012-11-23       Impact factor: 6.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.